Page 34 - GPD-3-4

Gene & Protein in Disease GLUT5 in cancer development and therapy

doi: 10.1038/srep44541 74. Kawai K, Uemura M, Munakata K, et al. Fructose-
bisphosphate aldolase A is a key regulator of hypoxic
67. Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K/ adaptation in colorectal cancer cells and involved in
Akt pathway and glucose metabolism: A dangerous liaison treatment resistance and poor prognosis. Int J Oncol.
in cancer. Int J Biol Sci. 2024;20:3113-3125.
2017;50:525-534.
doi: 10.7150/ijbs.89942
doi: 10.3892/ijo.2016.3814
68. Navaei ZN, Khalili-Tanha G, Zangouei AS, 75. Li X, Jiang F, Ge Z, et al. Fructose-bisphosphate aldolase a
Abbaszadegan MR, Moghbeli M. PI3K/AKT signaling regulates hypoxic adaptation in hepatocellular carcinoma
pathway as a critical regulator of Cisplatin response in and involved with tumor malignancy. Dig Dis Sci.
tumor cells. Oncol Res. 2021;29:235-250.
2019;64:3215-3227.
doi: 10.32604/or.2022.025323
doi: 10.1007/s10620-019-05642-2
69. Liu R, Chen Y, Liu G, et al. PI3K/AKT pathway as a key link 76. Huang Z, Hua Y, Tian Y, et al. High expression of fructose-
modulates the multidrug resistance of cancers. Cell Death bisphosphate aldolase A induces progression of renal cell
Dis. 2020;11:797. carcinoma. Oncol Rep. 2018;39:2996-3006.
doi: 10.1038/s41419-020-02998-6 doi: 10.3892/or.2018.6378

70. Bansal A, Simon MC. Glutathione metabolism in 77. Cunha A, Silva PMA, Sarmento B, Queirós O. Targeting
cancer progression and treatment resistance. J Cell Biol. glucose metabolism in cancer cells as an approach to
2018;217:2291-2298. overcoming drug resistance. Pharmaceutics. 2023;15:2610.
doi: 10.1083/jcb.201804161 doi: 10.3390/pharmaceutics15112610
71. Pungsrinont T, Kallenbach J, Baniahmad A. Role of PI3K- 78. Chałaśkiewicz K, Karaś K, Zakłos-Szyda M, et al.
AKT-mTOR pathway as a pro-survival signaling and Trichostatin A inhibits expression of the human SLC2A5
resistance-mediating mechanism to therapy of prostate gene via SNAI1/SNAI2 transcription factors and sensitizes
cancer. Int J Mol Sci. 2021;22:11088. colon cancer cells to platinum compounds. Eur J Pharmacol.

doi: 10.3390/ijms222011088 2023;949:175728.
72. Kuehm LM, Khojandi N, Piening A, et al. Fructose promotes doi: 10.1016/j.ejphar.2023.175728
cytoprotection in melanoma tumors and resistance to 79. Taylor SR, Falcone JN, Cantley LC, Goncalves MD.
immunotherapy. Cancer Immunol Res. 2021;9:227-238. Developing dietary interventions as therapy for cancer. Nat

doi: 10.1158/2326-6066.CIR-20-0396 Rev Cancer. 2022;22:452-466.
73. Li H, Li M, Pang Y, Liu F, Sheng D, Cheng X. doi: 10.1038/s41568-022-00485-y
Fructose1,6bisphosphatase1 decrease may promote 80. Mohanty P, Pande B, Acharya R, Bhaskar L, Verma HK.
carcinogenesis and chemoresistance in cervical cancer. Mol Unravelling the triad of lung cancer, drug resistance, and
Med Rep. 2017;16:8563-8571. metabolic pathways. Diseases. 2024;12:93.
doi: 10.3892/mmr.2017.7665 doi: 10.3390/diseases12050093

Volume 3 Issue 4 (2024) 13 doi: 10.36922/gpd.4171